Pharmacy Workforce

Message from the CEO: ASHP Mourns Lives Lost in Tulsa Medical Center Shooting

Published: June 2, 2022

ASHP Chief Executive Officer Paul W. Abramowitz, PharmD, ScD, (Hon), FASHP, released a statement about the latest mass shooting in Tulsa, Oklahoma: 

The national epidemic of firearms deaths continues, this time claiming the lives of at least four people at the St. Francis Health System campus in Tulsa, Oklahoma.

This event — the latest in a growing number of shooting deaths — is a tragic reminder that violence can reach us all in our workplaces and as we go about our daily lives.

The nation is straining under the toll of violence, and we must find solutions to this public health crisis.

We extend our heartfelt condolences to the victims and loved ones of this terrible attack and offer our support to our colleagues at the Saint Francis Health System and to their families and the community.

ASHP mourns all those whose lives have been lost to all-too-frequent mass shootings.

ASHP policy 2017, Role of the Pharmacy Workforce in Preventing Accidental and Intentional Firearm Injury and Death, and ASHP policy 2035, Role of the Pharmacy Workforce in Violence Prevention, recognizes that violence is a public health crisis.

ASHP supports a vision of pharmacy that improves the health and well-being of our professional colleagues, neighbors, our communities, and the nation. The pharmacy workforce has important roles in a comprehensive public health and medical approach to violence prevention, including leadership roles in their communities and workplaces.

We will continue to support the profession and work with our healthcare colleagues to counter the societal and public health impact of violence. 

Paul W. Abramowitz, PharmD, ScD, (Hon), FASHP







Posted June 2, 2022

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information